Form 8-K Sun BioPharma, Inc. For: Mar 22 – StreetInsider.com

UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. FORM 8-K. CURRENT REPORT. Pursuant to Section 13 or 15(d) of …